Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
radiopharmaceuticals
Manufacturing
Ratio, Ionetix ink separate radiopharmaceutical isotope deals
Ratio Therapeutics and Ionetix have each inked separate deals to boost the production of the key radiopharmaceutical isotope actinium-225.
Joseph Keenan
Jun 23, 2025 11:08am
Ratio inks deal to build radiopharma production facility in Utah
May 13, 2025 10:07am
Novartis builds momentum with new drug launches
Apr 29, 2025 10:52am
Novartis unveils $23B investment to beef up US manufacturing, R&D
Apr 10, 2025 3:18pm
CDMO PharmaLogic takes majority stake in radiopharma pro Agilera
Apr 9, 2025 3:00pm
Novartis' Pluvicto wins key FDA nod toward $5B-plus sales target
Mar 28, 2025 3:02pm
